 |
8 Diseases |  |
0 Trials |
|
0 Trials |  |
6 News |  |
- Adipoplus (autologous cultured adipose-derived stem cells) / Anterogen
Enrollment change, Trial termination, Trial primary completion date: Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211) (clinicaltrials.gov) - Nov 23, 2016
P=N/A, N=6, Terminated, Sponsor: Anterogen Co., Ltd.
N=40 --> 6 | Active, not recruiting --> Terminated | Trial primary completion date: Feb 2013 --> Sep 2014; Difficulty recruiting subjects
- Adipoplus (autologous cultured adipose-derived stem cells) / Anterogen
Enrollment change, Trial termination, Trial primary completion date: Clinical Trials of Autologous Cultured Adipose-derived Stem Cells (ANTG-ASC) on Complex Fistula (clinicaltrials.gov) - Nov 23, 2016
P2, N=15, Terminated, Sponsor: Anterogen Co., Ltd.
N=40 --> 6 | Active, not recruiting --> Terminated | Trial primary completion date: Feb 2013 --> Sep 2014; Difficulty recruiting subjects N=40 --> 15 | Recruiting --> Terminated | Trial primary completion date: Dec 2012 --> Sep 2014; Difficulty recruiting subjects.
- | Adipoplus (autologous cultured adipose-derived stem cells) / Anterogen
Trial completion: Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn's Fistula (clinicaltrials.gov) - Nov 23, 2016
P2, N=37, Completed, Sponsor: Anterogen Co., Ltd.
N=40 --> 15 | Recruiting --> Terminated | Trial primary completion date: Dec 2012 --> Sep 2014; Difficulty recruiting subjects. Active, not recruiting --> Completed
- Adipoplus (autologous cultured adipose-derived stem cells) / Anterogen
Clinical: Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211) (clinicaltrials.gov) - Jun 18, 2012
P=N/A, N=40, Active, not recruiting, Sponsor: Anterogen Co., Ltd.
- | Adipoplus (autologous cultured adipose-derived stem cells) / Anterogen
Enrollment closed: Follow-up Study of Autologous Cultured Adipose-derived Stem Cells for the Crohn's Fistula (clinicaltrials.gov) - Mar 13, 2012
P2, N=40, Active, not recruiting, Sponsor: Anterogen Co., Ltd.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Adipoplus (autologous cultured adipose-derived stem cells) / Anterogen
Trial completion: Safety and Efficacy Study of Autologous Cultured Adipose -Derived Stem Cells for the Crohn's Fistula (clinicaltrials.gov) - Mar 13, 2012
P2, N=40, Completed, Sponsor: Anterogen Co., Ltd.
Recruiting --> Active, not recruiting Recruiting --> Completed